# The Effects of Human Endotoxemia on Functional Capacity of Hematopoietic Stem and Progenitor Cells

> **NCT05570643** · NA · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 12 (actual)

## Conditions studied

- Sepsis, Endotoxemia, Immunosuppression

## Interventions

- **DRUG:** LPS
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05570643
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-05
- **Primary completion:** 2018-06-28
- **Final completion:** 2018-06-28
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2022-10-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05570643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05570643, "The Effects of Human Endotoxemia on Functional Capacity of Hematopoietic Stem and Progenitor Cells". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05570643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*